Found: 2
Select item for more details and to access through your institution.
A Korean Post-Marketing Surveillance Study of Dolutegravir Single-Agent Tablets in Patients with HIV-1.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, n. 4, p. 711, doi. 10.3947/ic.2022.0058
- By:
- Publication type:
- Article
Switching to DTG/3TC Is non-inferior to continuing current antiretroviral regimen at week 48: SALSA subgroup analyses.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S298
- By:
- Publication type:
- Article